110 related articles for article (PubMed ID: 8114501)
1. Computer calculation of multiple binding equilibrium isotherms: application to the binding of bivalent ligands to antibodies interacting with cell surface Fc-receptors.
Barbet J; Le Doussal JM; Gruaz-Guyon A; Martin M; Gautherot E; Delaage M
J Theor Biol; 1993 Dec; 165(3):321-40. PubMed ID: 8114501
[TBL] [Abstract][Full Text] [Related]
2. Cross-linking of Fc gamma receptors and surface antibodies. Theory and application.
Wofsy C; Goldstein B
J Immunol; 1990 Sep; 145(6):1814-25. PubMed ID: 2144009
[TBL] [Abstract][Full Text] [Related]
3. Theory of equilibrium binding of symmetric bivalent haptens to cell surface antibody: application to histamine release from basophils.
Dembo M; Goldstein B
J Immunol; 1978 Jul; 121(1):345-53. PubMed ID: 78945
[TBL] [Abstract][Full Text] [Related]
4. The influence of rigid or flexible linkage between two ligands on the effective affinity and avidity for reversible interactions with bivalent receptors.
Bobrovnik SA
J Mol Recognit; 2007; 20(4):253-62. PubMed ID: 17847051
[TBL] [Abstract][Full Text] [Related]
5. A rigorous multiple independent binding site model for determining cell-based equilibrium dissociation constants.
Drake AW; Klakamp SL
J Immunol Methods; 2007 Jan; 318(1-2):147-52. PubMed ID: 17141800
[TBL] [Abstract][Full Text] [Related]
6. Application of fluorescence correlation spectroscopy to hapten-antibody binding.
Hazlett TL; Ruan Q; Tetin SY
Methods Mol Biol; 2005; 305():415-38. PubMed ID: 15940009
[TBL] [Abstract][Full Text] [Related]
7. Study of ligand-receptor binding using SPME: investigation of receptor, free, and total ligand concentrations.
Musteata FM; Pawliszyn J
J Proteome Res; 2005; 4(3):789-800. PubMed ID: 15952725
[TBL] [Abstract][Full Text] [Related]
8. Divergent signal transduction pathways and effects on natural killer cell functions induced by interaction of Fc receptors with physiologic ligands or antireceptor antibodies.
Sulica A; Chambers WH; Manciulea M; Metes D; Corey S; Rabinowich H; Whiteside TL; Herberman RB
Nat Immun; 1995; 14(3):123-33. PubMed ID: 8832896
[TBL] [Abstract][Full Text] [Related]
9. New capabilities in determining the binding parameters for ligand-receptor interaction.
Bobrovnik S
J Biochem Biophys Methods; 2005 Oct; 65(1):30-44. PubMed ID: 16188321
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of multivalent antigen DNP-BSA binding to IgE-Fc epsilon RI in relationship to the stimulated tyrosine phosphorylation of Fc epsilon RI.
Xu K; Goldstein B; Holowka D; Baird B
J Immunol; 1998 Apr; 160(7):3225-35. PubMed ID: 9531278
[TBL] [Abstract][Full Text] [Related]
11. Binding mechanisms of PEGylated ligands reveal multiple effects of the PEG scaffold.
Das R; Baird E; Allen S; Baird B; Holowka D; Goldstein B
Biochemistry; 2008 Jan; 47(3):1017-30. PubMed ID: 18154361
[TBL] [Abstract][Full Text] [Related]
12. Nonspanning bivalent ligands as improved surface receptor binding inhibitors of the cholera toxin B pentamer.
Pickens JC; Mitchell DD; Liu J; Tan X; Zhang Z; Verlinde CL; Hol WG; Fan E
Chem Biol; 2004 Sep; 11(9):1205-15. PubMed ID: 15380181
[TBL] [Abstract][Full Text] [Related]
13. Binding of different ligands to IgM-Fc receptors of rat leucocytes.
Uher F; Dobronyi I; Gergely J
Immunology; 1982 Feb; 45(2):387-93. PubMed ID: 7061103
[TBL] [Abstract][Full Text] [Related]
14. Theory of equilibrium binding of a bivalent ligand to cell surface antibody: the effect of antibody heterogeneity on cross-linking.
Goldstein B; Wofsy C
J Math Biol; 1980 Dec; 10(4):347-66. PubMed ID: 7276759
[TBL] [Abstract][Full Text] [Related]
15. A membrane antibody receptor for noninvasive imaging of gene expression.
Roffler SR; Wang HE; Yu HM; Chang WD; Cheng CM; Lu YL; Chen BM; Cheng TL
Gene Ther; 2006 Mar; 13(5):412-20. PubMed ID: 16267569
[TBL] [Abstract][Full Text] [Related]
16. Impact of methionine oxidation on the binding of human IgG1 to Fc Rn and Fc gamma receptors.
Bertolotti-Ciarlet A; Wang W; Lownes R; Pristatsky P; Fang Y; McKelvey T; Li Y; Li Y; Drummond J; Prueksaritanont T; Vlasak J
Mol Immunol; 2009 May; 46(8-9):1878-82. PubMed ID: 19269032
[TBL] [Abstract][Full Text] [Related]
17. Automated docking of ligands to antibodies: methods and applications.
Sotriffer CA; Flader W; Winger RH; Rode BM; Liedl KR; Varga JM
Methods; 2000 Mar; 20(3):280-91. PubMed ID: 10694451
[TBL] [Abstract][Full Text] [Related]
18. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
19. Insights into immunoglobulin E receptor signaling from structurally defined ligands.
Holowka D; Sil D; Torigoe C; Baird B
Immunol Rev; 2007 Jun; 217():269-79. PubMed ID: 17498065
[TBL] [Abstract][Full Text] [Related]
20. Interaction of a monoclonal IgE-specific antibody with cell-surface IgE-Fc epsilon RI: characterization of equilibrium binding and secretory response.
Posner RG; Paar JM; Licht A; Pecht I; Conrad DH; Hlavacek WS
Biochemistry; 2004 Sep; 43(35):11352-60. PubMed ID: 15366945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
